Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Meropenem-vaborbactam is being compared to piperacillin-tazobactam in the treatment of adults with complicated urinary tract infection (cUTI) or acute pyelonephritis (AP).
Epistemonikos ID: 046ac41fb165c064a77556e36f1efd4acdeb0cde
First added on: May 11, 2024